Level 3: Channelopathies
Level 2: Neurology and neurodevelopmental disorders
Version 1.46
|
review
|
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
|
Sources
- Expert Review Green
- Eligibility statement prior genetic testing
- UKGTN
- Illumina TruGenome Clinical Sequencing Services
- Radboud University Medical Center, Nijmegen
Phenotypes
- Hyperkalemic periodic paralysis, type 2, 170500
- Myasthenic syndrome, acetazolamide-responsive, 614198
- Hypokalemic periodic paralysis, type 2, 613
- Potassium-Aggravated Myotonia
- Hyperkalemic Periodic Paralysis
- Hypokalemic Periodic Paralysis
- Thyrotoxic Periodic Paralysis, Susceptibility To, 2
- Myotonia
- Episodic weakness
|
Level 2: Viral research
Version 1.141
|
review
|
Unknown
|
Sources
|
Level 3: Neuromuscular disorders
Level 2: Neurology and neurodevelopmental disorders
Version 3.48
Latest signed off version: v3.0
(22 Mar 2023)
Component of the following Super Panels:
Hypotonic infant
Other rare neuromuscular disorders
|
review
|
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
|
Sources
- NHS GMS
- Expert Review Green
- Expert list
Phenotypes
- SCN4A-related muscle disorders
|
Version 19.202
Latest signed off version: v19.1
(22 Mar 2023)
|
review
|
BIALLELIC, autosomal or pseudoautosomal
|
Sources
Phenotypes
- congenital myopathy
- Congenital Myasthenic Syndrome, Recessive
- congenital myasthenic syndromes
- Myasthenic syndrome, congenital, 16, 614198
|
Version 0.36
|
review
|
Not set
|
Sources
|
Version 3.10
Latest signed off version: v3.0
(22 Mar 2023)
|
review
|
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
|
Sources
- Expert Review Red
- NHS GMS
- London North GLH
- Wessex and West Midlands GLH
Phenotypes
- Thyrotoxic Periodic Paralysis, Susceptibility To, 2
- Hypokalemic periodic paralysis, type 2, 613
- Potassium-Aggravated Myotonia
- Hyperkalemic periodic paralysis, type 2, 170500
- Myasthenic syndrome, acetazolamide-responsive, 614198
- Hyperkalemic Periodic Paralysis
- Episodic weakness
- Myotonia
- Hypokalemic Periodic Paralysis
|
Level 3: Neuromuscular disorders
Level 2: Neurology and neurodevelopmental disorders
Version 5.22
Latest signed off version: v5.0
(22 Mar 2023)
|
review
|
BIALLELIC, autosomal or pseudoautosomal
|
Sources
- Expert Review Green
- Radboud University Medical Center, Nijmegen
- Emory Genetics Laboratory
- Illumina TruGenome Clinical Sequencing Services
Phenotypes
- Myasthenic syndrome, congenital, 16, OMIM:614198, Congenital myasthenic syndrome 16, MONDO:0013620
|
Level 3: Neuromuscular disorders
Level 2: Neurology and neurodevelopmental disorders
Version 4.37
Latest signed off version: v4.0
(22 Mar 2023)
Component of the following Super Panels:
Hypotonic infant
Other rare neuromuscular disorders
|
review
|
BIALLELIC, autosomal or pseudoautosomal
|
Sources
- NHS GMS
- London South GLH
- Expert Review Green
- Expert Review
Phenotypes
- Congenital myopathy, MONDO:0019952
|
Version 3.5
Latest signed off version: v3.0
(22 Mar 2023)
|
review
|
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
|
Sources
- Expert Review Green
- NHS GMS
- London North GLH
Phenotypes
- Hypokalemic periodic paralysis, type 2 OMIM:613345
- Hyperkalemic periodic paralysis, type 2 OMIM:170500
- Paramyotonia congenita OMIM:168300
- Congenital myopathy MONDO:0019952.
|
Level 3: Neuromuscular disorders
Level 2: Neurology and neurodevelopmental disorders
Version 4.5
Latest signed off version: v4.0
(22 Mar 2023)
Component of the following Super Panels:
Hypotonic infant
Other rare neuromuscular disorders
|
review
|
BIALLELIC, autosomal or pseudoautosomal
|
Sources
- NHS GMS
- Wessex and West Midlands GLH
- Radboud University Medical Center, Nijmegen
- Emory Genetics Laboratory
- Illumina TruGenome Clinical Sequencing Services
Phenotypes
- Myasthenic syndrome, congenital, 16, OMIM:614198
|
Level 3: Neuromuscular disorders
Level 2: Neurology and neurodevelopmental disorders
Version 4.32
Latest signed off version: v4.0
(22 Mar 2023)
Component of the following Super Panels:
Hypotonic infant
Other rare neuromuscular disorders
|
review
|
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
|
Sources
- Expert Review Red
- NHS GMS
- Yorkshire and North East GLH
- Expert Review
Phenotypes
- Hyperkalemic periodic paralysis, type 2, 170500
- Hyperkalemic periodic paralysis
|
Version 3.157
Latest signed off version: v3.0
(22 Mar 2023)
|
review
|
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
|
Sources
- Expert Review Green
- PAGE DD-Gene2Phenotype
Phenotypes
- PARAMYOTONIA CONGENITA OF VON EULENBURG
- HYPERKALEMIC PERIODIC PARALYSIS TYPE 1
- HYPOKALEMIC PERIODIC PARALYSIS
|
Level 3: Craniosynostosis syndromes
Level 2: Skeletal disorders
Version 4.180
Latest signed off version: v4.0
(22 Mar 2023)
|
review
|
Not set
|
Sources
|
Version 3.87
Latest signed off version: v3.1
(22 Mar 2023)
Component of the following Super Panels:
Paediatric disorders
|
review
|
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
|
Sources
- DD-Gene2Phenotype
- Expert Review Green
Phenotypes
- HYPOKALEMIC PERIODIC PARALYSIS 613345
- PARAMYOTONIA CONGENITA OF VON EULENBURG 168300
- HYPERKALEMIC PERIODIC PARALYSIS TYPE 1 170500
|
Level 3: Neurodevelopmental disorders
Level 2: Neurology and neurodevelopmental disorders
Version 5.536
Latest signed off version: v5.0
(22 Mar 2023)
Component of the following Super Panels:
Childhood onset leukodystrophy
Hypotonic infant
Paediatric disorders
|
review
|
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
|
Sources
- Expert Review Red
- BRIDGE study SPEED NEURO Tier1 Gene
Phenotypes
- Hyperkalemic periodic paralysis, type 2, 170500
- Paramyotonia
- congenita, 168300
- Myotonia congenita, atypical, acetazolamide-responsive, 608390
- Myasthenic syndrome, acetazolamide-responsive, 614198
- Hypokalemic periodic paralysis, type 2, 613345
|
Version 1.184
|
review
|
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
|
Sources
- Next Generation Children Project
- Expert Review Green
- Expert list
Phenotypes
- Hyperkalemic periodic paralysis, type 2, 170500
- Myasthenic syndrome, congenital, 16, 614198
- Myotonia congenita, atypical, acetazolamide-responsive, 608390
- Hypokalemic periodic paralysis, type 2, 613345
- Paramyotonia congenita, 168300
|
Level 3: Neuromuscular disorders
Level 2: Neurology and neurodevelopmental disorders
Version 1.18
Latest signed off version: v1.7
(31 May 2023)
|
review
|
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
|
Sources
- NHS GMS
- Expert Review Green
Phenotypes
- Exercise induced cramps, muscle fatigue, myopathy
- Hyperkalemic periodic paralysis, type 2, OMIM:170500
- Hypokalemic periodic paralysis, type 2, OMIM:613345
- Paramyotonia congenita, OMIM:168300
- Myotonia congenita, atypical, acetazolamide-responsive, OMIM:608390
- Myasthenic syndrome, congenital, 16, OMIM:614198
|